What the company does
Daehan Nupharm is a South Korean pharmaceutical company that develops and supplies finished medicines, prescription and over-the-counter drugs used by patients and healthcare providers.
It is listed on KOSDAQ, Korea's technology and small-cap stock exchange. The filing's table of contents covers product lines, raw materials and production facilities, sales activity, and active research and development programs, indicating a broad pharmaceutical operation spanning manufacturing inputs through to commercialized products.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue · FY2025
US$146.7M
▲ +0.1% YoY
Operating profit · FY2025
US$8.5M
▼ −37.2% YoY
Net income · FY2025
US$11.1M
▼ −1.4% YoY
Revenue
- FY2023US$148M
- FY2024US$146.5M
- FY2025US$146.7M
Operating profit
- FY2023US$13.6M
- FY2024US$13.5M
- FY2025US$8.5M
Net income
- FY2023US$9.1M
- FY2024US$11.2M
- FY2025US$11.1M
Key ratios (FY2025)
ROE
10.9%
Debt/Eq
93.8%
Op. margin
5.8%
Net margin
7.5%
Rev. YoY
▲ +0.1%
Price charts coming soon
Interactive price history isn't here yet. Would you use it?